Guangyu Bai

Guangyu Bai practices at Methodist Southlake Medical Center in Southlake, Texas, part of Methodist Hospitals of Dallas.

Guangyu Bai's NPI, 1386286474, was assigned on October 10, 2019. Guangyu Bai holds Indiana license 01089799A.

Guangyu Bai's primary practice is Methodist Southlake Medical Center, at 421 E State Highway 114, Southlake, TX 76092 in Tarrant County. The practice phone is (878) 654-4400. Guangyu Bai also practices at Methodist Southlake Hospital, 8701 Broadway, Merrillville, IN 46410.

Guangyu Bai's primary practice is Methodist Southlake Medical Center in Southlake, Texas, part of Methodist Hospitals of Dallas. Guangyu Bai is also affiliated with Mercyhealth Hospital and Trauma Center-Janesville. The medical group on file is Vituity. Dmand AI also links Guangyu Bai to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Guangyu Bai practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Guangyu Bai's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Guangyu Bai's licenses on file in 2 states: Indiana and Wisconsin.

CMS data shows 513 Medicare services from Guangyu Bai across 4 procedure codes in 2024, for 350 Medicare patients. Medicare paid $47,459 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 350 Medicare patients who saw Guangyu Bai in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Guangyu Bai's median patient age at 57, with 54% women.

In 2024, Guangyu Bai wrote 221 Medicare Part D claims for 176 patients. 91% of them were for generic drugs. CMS names the drug for 79 of them, across 3 drugs with 11 or more claims each, at $337 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Guangyu Bai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.